Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Research on Haploidentical Transplantation in Severe Aplastic Anemia Using Reduced-intensity Fludarabine-based Conditioning

NCT03246178 is registered in ClinicalTrials.gov with Wu Xiaoxiong as lead sponsor.

NCT NCT03246178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03246178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Research on Haploidentical Transplantation in Severe Aplastic Anemia Using Reduced-intensity Fludarabine-based Conditioning
Lead sponsor
Wu Xiaoxiong
Phase
Not applicable
Overall status
Unknown status
Start date
July 10, 2017
Completion date
December 1, 2020
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe aplastic anemia